CareMax — Q1 2022 Earnings Presentation
14 slides from CareMax's earnings presentation, May 10, 2022
Slide 1: First Quarter 2022 Earnings Presentation
First Quarter 2022 Earnings Presentation May 10, 2022 EX – 99.2
Slide 2: Disclaimer
Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or
Slide 3: CareMax at a Glance
CareMax at a Glance 34K+ Medicare Advantage Members 2011 Year Founded 48 Medical Centers 100+ Employed Providers 84K+ Total Members We are… A founder-led, technology-enabled, whole person healthcare platform providing value-based care and chronic disease management to seniors. Our mission… Is to emp
Slide 4: First Quarter 2022 Update
First Quarter 2022 Update Reported revenue of $137M for 1Q22, of which ~93% was risk-based revenue Achieved a 72.6% Medical Expense Ratio for 1Q221 Medicare Advantage membership of 34,000, up 106% year-over-year2 Strong patient engagement evidenced by over 75% of members seen by their primary care p
Slide 5: Continued Growth in Center Footprint and Medicare Advantage Membership
We Expect Continued Growth in Our Center Footprint and Medicare Advantage Membership Centers Medicare Advantage Members 10x ~13x 2021 2017 2019 2018 2020 2022E 60 38,000 - 40,000 2017 2022E 2018 2019 2020 2021 1Q22 YE22 1Q22 YE22
Slide 6: Lowered COVID Admissions Among Our Members with Each Successive Wave
We Have Managed to Lower COVID Admissions Among Our Members with Each Successive Wave COVID Admission Volumes by Quarter1 Quarterly Inpatient Admissions per Thousand Legacy CareMax and IMC Medicare only. D614G Variant Alpha Variant Delta Variant Omicron Variant
Slide 7: Reaffirming Financial Outlook for Full Year 2022
Reaffirming Financial Outlook for Full Year 2022 FY 2022 Guidance YoY % growth Medicare Advantage Membership 38,000 to 40,000 13% to 19% Revenue $540 million to $560 million 34% to 39%1 Adjusted EBITDA $30 million to $40 million 125% to 200%1 Year-End Center Count 60 (15 openings) 33% Compared to pr
Slide 8: First Quarter 2022 Financial Supplement
First Quarter 2022 Financial Supplement
Slide 9: Reconciliation to Non-GAAP Financial Metrics
Reconciliation to Non-GAAP Financial Metrics 1Q22 Non-GAAP Reconciliation 1Q21 Non-GAAP Reconciliation Reflects impact of business combination of CareMax, IMC Medical Group Holdings, and Care Holdings and other pro forma adjustments as may arise from the combination. $'000s GAAP 1Q22 Adjustments Non
Slide 10: Reconciliation to Adjusted EBITDA
Reconciliation to Adjusted EBITDA Note: Pro forma and non-GAAP figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods (the “Business Combination”). Totals may not sum due to rounding. Pro forma net income replaces historical interest
Slide 11: Historical Non-GAAP Financial Summary
Historical Non-GAAP Financial Summary Note: Figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods. Totals may not sum due to rounding. Includes operating losses incurred by de novo centers up to 18 months after opening. Non-GAAP Inco
Slide 12: Capitalization and Liquidity
Capitalization and Liquidity Excludes unvested warrants as of March 31, 2022. Warrants have a strike price of $11.50/share and (other than the Related warrants) are subject to a $18.00 redemption cap. Warrants are currently out of the money based on CareMax’s closing share price as of May 9, 2022. T
Slide 13: Pro Forma Impact of New Credit Agreement
Pro Forma Impact of New Credit Agreement Note: The above description of the new Credit Agreement is not complete and is qualified in its entirety by reference to the full text of the Credit Agreement. Consists of outstanding debt on vehicles and furniture. We have entered into a new Credit Agreement
Slide 14: Q&A
Caremax Q&A